Clinical trial
Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on…
NCT02682381 · Shire, Industry · Completed
Key facts
| NCT number | NCT02682381 |
|---|---|
| Title | Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition |
| Official title | A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Short Bowel Syndrome |
| Intervention type | Drug, Other |
| Interventions | Teduglutide 0.05mg/kg, Teduglutide 0.025 mg/kg, Standard of Care |
| Enrollment | 59 |
| Start date | Jun 23, 2016 |
| Primary completion | Aug 18, 2017 |
| Completion | Aug 18, 2017 |
| First posted | Feb 15, 2016 |
| Last update posted | Jun 9, 2021 |
| Countries | Belgium, Canada, Finland, Germany, Italy, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: